New model could spot High-Risk COPD patients with hidden muscle loss

NCT ID NCT07136246

Completed Knowledge-focused Sponsor: Fudan University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study from Fudan University looked at 200 older adults with COPD who also have sarcopenic obesity — a condition where muscle loss and excess fat occur together. Researchers used a device called InBody S10 to measure body composition and phase angles, aiming to build a model that predicts disease severity, quality of life, and risk of flare-ups. The goal is to improve early screening and personalized care for this specific group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple tool to predict health outcomes in older adults with both COPD and sarcopenic obesity, enabling earlier interventions.
What could go wrong: This is an observational study, not a treatment trial. The model may not be accurate for all patients or lead to direct improvements in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COPD SARCOPENIC OBESITY

Contacts and locations

Locations

Huadong hospital, Fudan University

Shanghai, Shanghai Municipality, 200040, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.